Deep Health Ai India Ltd vs Fredun Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Deep Health AI India Ltd is ₹ 2.3 as of 18 May 15:30 . The P/E Ratio of Deep Health AI India Ltd is 24.9 as of March 2025 .The P/E Ratio of Fredun Pharmaceuticals Ltd is 16 as of March 2025 . The Market Cap of Deep Health AI India Ltd is ₹ 14.34 crore as of March 2025 .The Market Cap of Fredun Pharmaceuticals Ltd is ₹ 315.67 crore as of March 2025 . The revenue of Deep Health AI India Ltd for the Dec '25 is ₹ 4.21 crore as compare to the Sep '25 revenue of ₹ 3.51 crore. This represent the growth of 19.94% The revenue of Fredun Pharmaceuticals Ltd for the Dec '25 is ₹ 160.92 crore as compare to the Sep '25 revenue of ₹ 145.29 crore. This represent the growth of 10.76% The ebitda of Deep Health AI India Ltd for the Dec '25 is ₹ 3.67 crore as compare to the Sep '25 ebitda of ₹ 3.39 crore. This represent the growth of 8.26% The ebitda of Fredun Pharmaceuticals Ltd for the Dec '25 is ₹ 26.34 crore as compare to the Sep '25 ebitda of ₹ 22.33 crore. This represent the growth of 17.96% The net profit of Deep Health AI India Ltd changed from ₹ 0.29 crore to ₹ 3.04 crore over 7 quarters. This represents a CAGR of 282.94% The net profit of Fredun Pharmaceuticals Ltd changed from ₹ 13.74 crore to ₹ 10.48 crore over 5 quarters. This represents a CAGR of -19.48% The Dividend Payout of Deep Health AI India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Fredun Pharmaceuticals Ltd changed from 13.9 % on March 2021 to 1.59 % on March 2025 . This represents a CAGR of -35.18% over 5 years .

About Deep Health AI India Ltd

Deep Diamond India Limited was established in 1994, with the object to engaged in the manufacture and wholesale of gold set jewellery with diamonds.
The company also deals in loose diamonds, solitaires, and gold frames.
It offers Pendants, Nose pins, Rings, Bangles, Earrings, Pendant sets, Necklace sets, Bracelets, and others. From financial year 2022-23, the Company has also started business of providing consultancy service to Pharmaceutical Industry. During year 2023, Company diversified its business into pharmaceuticals business with professional management team at its Board.
Located in Mumbai, Deep Diamond India is a pharmaceutical company that focuses on developing and marketing innovative drugs and therapies to address unmet medical needs.
Their product portfolio includes prescription drugs, over-the-counter medicines, and medical devices.

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94.
The Company was promoted by Nariman Medhora and Daulat N Medhora.
The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

FAQs for the comparison of Deep Health AI India Ltd and Fredun Pharmaceuticals Ltd

Which company has a larger market capitalization, Deep Diamond India Ltd or Fredun Pharmaceuticals Ltd?

Market cap of Deep Diamond India Ltd is 33 Cr while Market cap of Fredun Pharmaceuticals Ltd is 1,269 Cr

What are the key factors driving the stock performance of Deep Diamond India Ltd and Fredun Pharmaceuticals Ltd?

The stock performance of Deep Diamond India Ltd and Fredun Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deep Diamond India Ltd and Fredun Pharmaceuticals Ltd?

As of May 18, 2026, the Deep Diamond India Ltd stock price is INR ₹2.3. On the other hand, Fredun Pharmaceuticals Ltd stock price is INR ₹2302.55.

How do dividend payouts of Deep Diamond India Ltd and Fredun Pharmaceuticals Ltd compare?

To compare the dividend payouts of Deep Diamond India Ltd and Fredun Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.